Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

Press releases published on June 22, 2026

5 hours ago

Route 92 Medical Announces First Commercial Cases in Canada

Indeterminate GlobeNewswire

6 hours ago

St. Augustine Dentist Explains Why Replacing Missing Teeth Can Support Long-Term Oral Health

Indeterminate GlobeNewswire

6 hours ago

BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026

Indeterminate GlobeNewswire

6 hours ago

TETmedical Receives FDA Breakthrough Device Designation for NSE-FAST®, the First Rapid Test Designed to Aid in the Diagnosis of Acute Ischemic Stroke

Indeterminate GlobeNewswire

6 hours ago

BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives

Indeterminate GlobeNewswire

6 hours ago

Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026

Indeterminate GlobeNewswire

6 hours ago

FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations

Indeterminate GlobeNewswire

6 hours ago

Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds

Indeterminate GlobeNewswire

6 hours ago

CureWise Founder and CEO Steve Brown to Speak at Aspen Ideas: Health 2026 and Launch AI-Powered Precision Oncology Platform

Indeterminate GlobeNewswire

6 hours ago

TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation

Indeterminate GlobeNewswire

6 hours ago

Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)

Indeterminate GlobeNewswire

6 hours ago

NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression

Indeterminate GlobeNewswire

6 hours ago

Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program

Indeterminate GlobeNewswire

6 hours ago

MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder

Indeterminate GlobeNewswire

6 hours ago

Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus

Indeterminate GlobeNewswire

6 hours ago

Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening

Indeterminate GlobeNewswire

6 hours ago

Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031

Indeterminate GlobeNewswire

6 hours ago

Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and Namodenoson

Indeterminate GlobeNewswire

6 hours ago

QTREX Announces Management Share Purchase Plan

Indeterminate GlobeNewswire

7 hours ago

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire